|Global media hype about CRBC construction of the Peljesac Bridge|
|Author: CSEBA / SEEbiz / Večernji list|
|9th February 2019|
|ZAGREB - The construction of Pelješac Bridge, the most important infrastructure project in Croatia that will connect two parts of the country, is also interested for the world media.|
Journalists from the Italian daily newspaper Corriera della Sera arrived on the construction site of the bridge in Komarna yesterday, and for that day there is also a British BBC team arriving there.
For instance, the Peljesac Bridge was written by both New York and the Financial Times, and the Swiss public radio was also reported about it.
Considering that the bridge is being built by the Chinese consortium led by China Road and Bridge Corporation (CRBC), numerous media outlets from China reported it. And just a Chinese contractor is one of the main reasons for such a great interest of the world's media for the bridge that will connect south with the rest of Croatia. CRBC is the first Chinese company to get the job of such a large infrastructure project on the EU soil, and this is a public tender co-financed by EU funds, Večernji list writes.
The New York Times wrote that the Peljesac Bridge for China is a road to Europe, but also that some people from the EU are not delighted that the Chinese company has broken into the European market. The Financial Times has, however, put a greater emphasis on the opposition of Bosnian Bosniak politicians from BiH's construction of the bridge. However, journalists of that journal explained to their readers why Croatia wants to build a bridge - to connect its territory and to be ready to enter the Schengen regime. The Swiss radio reported about the construction of the Peljesac Bridge in the context of the new Chinese Silk Road, which he made a series of reportages.
Foreign journalists are interested in all the technical specifications, which materials will be embedded and in what quantities, how the material will be delivered, what dynamics works, how the bridge looks and how much it will cost its construction. Foreign journalists also ask for an explanation of why Croatian territory is separated.
|31st March 2021|
|WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy|